$WTW

Willis Towers Watson Stock: Is Wall Street Bullish or Bearish?

Analysts covering Willis Towers Watson (WTW) have a consensus 'Moderate Buy' rating, with 14 'Strong Buy' and 9 'Hold' ratings. This is slightly less bullish than three months ago. TD Cowen raised its price target to $455, while the mean target is $380.95, implying an 11% premium to current levels.

Original reporting
Published Aug 27, 2026, 12:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 5:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Willis Towers Watson Stock: Is Wall Street Bullish or Bearish? — source image
Decision brief

The 30-second read

$WTWBullishMed
01

Why it matters

The price target upgrade signals increased upside potential, but without fresh corporate catalysts the move may be modest.

02

Market read

Analyst target revision provides a short-term trading cue for investors in WTW and related financial services stocks.

03

What to watch

No new earnings data; price may already reflect expectations.

Relevance 6/10Novelty 6/10Timing: recent

Background

Willis Towers Watson (WTW) is a global advisory, broking and solutions company. Analyst consensus remains a Moderate Buy.

Company-level read

Ticker impact

$WTWBullishMedium confidence
Context

TD Cowen raised Willis Towers Watson's price target to $455 from $391, indicating a potential 32.6% upside.

Expected impact

Potential short-term price appreciation toward the new target range.

Evidence & confidence

Target increase of $64 reflects a material upside; however, no new corporate event accompanies it.

Market effects

May lift peer insurance and consulting stocks as analysts reassess valuation multiples.

Limited to U.S. markets where WTW trades.

Minor, confined to the financial services sector.

Counterpoint

Target raise could be premature if underlying earnings guidance remains unchanged.

Key entities

  • TD Cowen

    Raised WTW price target to $455.

Related articles

$WTWLow

Analysts’ Opinions Are Mixed on These Financial Stocks: Willis Towers Watson (WTW) and Raymond James Financial (RJF)

Analysts at TD Cowen maintained Buy ratings on Willis Towers Watson (WTW) with a $455 target, and Hold on Raymond James Financial (RJF) with a $161 target. WTW closed at $335.46, near its 52-week high, while RJF closed at $177.93. Analyst consensus for WTW is Moderate Buy with a $374.87 average target, and for RJF is Moderate Buy with a $185.80 average target.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on an earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). It outlined Propel, targeting $400 million run-rate savings by 2028 and enterprise margin of about 30%, plus $450 million Q2 buybacks.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on its earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). The company targets $400m run-rate savings by 2028 from a ~$625m AI investment and $360m free cash flow in the first half of 2026.

$WTWMed

Why is Willis Towers Watson stock climbing today?

Willis Towers Watson (WTW) shares rose about 1.5% after Q2 results beat expectations and prompted analyst target increases. According to the company, adjusted EPS was $3.35 vs $3.13 consensus, revenue about $2.47B vs $2.41B, with 5% organic growth. Goldman raised its target to $385 and UBS to $405 (both Buy), while Citigroup downgraded to Neutral with a $345 target.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Carl A. Hess Chief Financial Officer - Andrew Krasner President of Health, Wealth & Career - Julie Gebauer President of Risk & Broking - Lucy Clarke TAKEAWAYS Organic Revenue Growth -- 5%, reflecting strength in the Risk & Broking segment and steady performance in Health, Wealth & Career.